𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of β-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP

✍ Scribed by Rangaswamy Nagmani; David S. Pasco; Ruben D. Salas; Dennis R. Feller

Book ID
113993464
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
178 KB
Volume
65
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enterolactone restricts the proliferatio
Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro
✍ Mark J. McCann; Chris I. R. Gill; Trevor Linton; D. Berrar; Hugh McGlynn; Ian R. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

## Abstract Ecological data suggest a long‐term diet high in plant material rich in biologically active compounds, such as the lignans, can significantly influence the development of prostate cancer over the lifetime of an individual. The capacity of a pure mammalian lignan, enterolactone (ENL), to

Inhibitory effects of evodiamine on the
Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP
✍ Shu-Fen Kan; William J. Huang; Lie-Chwen Lin; Paulus S. Wang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 563 KB

## Abstract Evodiamine, isolated from a Chinese herbal drug named Wu‐Chu‐Yu, possesses many biological functions. Recently, it has been reported that Wu‐Chu‐Yu exerts an antiproliferative effect on several cancers. Prostate carcinoma initially occurs as an androgen‐dependent tumor and is the second